$10 Million Acquisition of Swedish Biotech Company

Boule Diagnostics
Representation of Boule Diagnostics, Inc., a Swedish manufacturer of blood testing and other instruments, in its acquisition of Clinical Diagnostic Solutions, Inc., a Florida manufacturer of blood reagents, in a transaction valued at approximately $10 million. This stock and cash merger transaction required structuring with Swedish counsel in the manner of the issuance of the Swedish company's stock to the selling shareholders.
Related Topics
Related Practices
RELATED PEOPLE
Alan D. Axelrod

Alan D. Axelrod

Partner
MORE EXPERIENCE
Experience
Representation of Leon Medical Centers Health Plans, Inc. (“LMCHP”), and its stockholders in connection with the acquisition by HealthSpring, Inc. (NYSE: HC), of all of the outstanding capital stock of privately-held LMCHP for $405 million in cash and HealthSpring stock.  We also negotiated a 1...
Experience
Lead counsel to AnsaldoBreda, Inc., an Italian global transportation company, in securing a $300 million contract award by Miami-Dade County for the procurement of 136 heavy rail (Metrorail) vehicles. This is the largest procurement by Miami-Dade County Transit outside of the construction contracts ...
Experience
Representation of equity investor in its successful bid for the deployment of the Red Compartida wholesale broadband network, an approximately $7 billion public-private partnership with the Mexican Secretariat of Communications and Transportation.
VIEW MORE EXPERIENCE